Interest Paid, Excluding Capitalized Interest, Operating Activities of Blueprint Medicines Corp from 31 Dec 2013 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Blueprint Medicines Corp quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD history and change rate from 31 Dec 2013 to 31 Mar 2025.
  • Blueprint Medicines Corp Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Mar 2025 was $21,465,000, a 50% increase year-over-year.
  • Blueprint Medicines Corp annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $79,852,000, a 108% increase from 2023.
  • Blueprint Medicines Corp annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $38,467,000, a 292% increase from 2022.
  • Blueprint Medicines Corp annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $9,814,000.
Source SEC data
View on sec.gov
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)

Blueprint Medicines Corp Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $21,465,000 +$7,185,000 +50% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q1 2024 $14,280,000 +$7,196,000 +102% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q1 2023 $7,084,000 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2019 $2,000 -$16,000 -89% 01 Jan 2019 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q1 2018 $18,000 -$32,000 -64% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $50,000 -$45,000 -47% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018 2018 Q1
Q1 2016 $95,000 -$25,000 -21% 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q1 2015 $120,000 +$81,000 +208% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016 2016 Q1
Q1 2014 $39,000 01 Jan 2014 31 Mar 2014 10-Q 11 Jun 2015 2015 Q1

Blueprint Medicines Corp Annual Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $79,852,000 +$41,385,000 +108% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025 2024 FY
2023 $38,467,000 +$28,653,000 +292% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025 2024 FY
2022 $9,814,000 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025 2024 FY
2019 $5,000 -$262,000 -98% 01 Jan 2019 31 Dec 2019 10-K 17 Feb 2021 2020 FY
2018 $267,000 +$116,000 +77% 01 Jan 2018 31 Dec 2018 10-K 17 Feb 2021 2020 FY
2017 $151,000 -$165,000 -52% 01 Jan 2017 31 Dec 2017 10-K 13 Feb 2020 2019 FY
2016 $316,000 -$136,000 -30% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $452,000 +$237,000 +110% 01 Jan 2015 31 Dec 2015 10-K 21 Feb 2018 2017 FY
2014 $215,000 +$162,000 +306% 01 Jan 2014 31 Dec 2014 10-K 09 Mar 2017 2016 FY
2013 $53,000 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.